ClinicalTrials HQ

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Recruiting · NCT06192615 · Registry updated 2026-09-14
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)Confusion, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorderRecruitingPhase 32026-09-14NCT06192615

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Massachusetts General Hospital758

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beth Israel Deaconess Medical CenterBostonUnited States462
Brigham and Women's HospitalBostonUnited States60
Cedars-Sinai Medical CenterLos AngelesUnited States392
Columbia University Medical centerNew YorkUnited States224
Duke University HospitalDurhamUnited States54
Massachusetts General HospitalBostonUnited States1015
Montefiore Medical CenterThe BronxUnited States198
Northwestern University Feinberg School Of MedicineChicagoUnited States49
University of California San FranciscoSan FranciscoUnited States4
University of Iowa Carver College of MedicineIowa CityUnited States1
University of Maryland School of MedicineBaltimoreUnited States30
University of Nebraska Medical CenterOmahaUnited States397
Vanderbilt University Medical CenterNashvilleUnited States427
Washington University School of MedicineSt LouisUnited States895